 | • レポートコード：MRC309Z7942 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の筋弛緩剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の筋弛緩剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 筋弛緩剤の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 筋弛緩剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・錠剤、カプセル 用途別セグメント ・病院、診療所、薬局 主要な市場プレーヤー ・Novartis、Viatris、Teva Pharmaceuticals、Endo Pharmaceuticals、Mayne Pharma、Merck & Co. Inc、GSK、Casper Pharma LLC、Bayer、BASF、ADVIL、Pfizer、Johnson & Johnson、Rosemont Pharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、筋弛緩剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な筋弛緩剤メーカーの企業概要、2019年～2022年までの筋弛緩剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な筋弛緩剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別筋弛緩剤の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの筋弛緩剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での筋弛緩剤市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および筋弛緩剤の産業チェーンを掲載しています。 ・第14、15章では、筋弛緩剤の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 筋弛緩剤の概要 - 種類別分析（2018年vs2022年vs2029年）：錠剤、カプセル - 用途別分析（2018年vs2022年vs2029年）：病院、診療所、薬局 - 世界の筋弛緩剤市場規模・予測 - 世界の筋弛緩剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Novartis、Viatris、Teva Pharmaceuticals、Endo Pharmaceuticals、Mayne Pharma、Merck & Co. Inc、GSK、Casper Pharma LLC、Bayer、BASF、ADVIL、Pfizer、Johnson & Johnson、Rosemont Pharmaceuticals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：錠剤、カプセル ・用途別分析2018年-2029年：病院、診療所、薬局 ・筋弛緩剤の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・筋弛緩剤のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・筋弛緩剤のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・筋弛緩剤の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・筋弛緩剤の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Muscle Relaxers market size was valued at USD 4012.9 million in 2022 and is forecast to a readjusted size of USD 5783.2 million by 2029 with a CAGR of 5.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
This report is a detailed and comprehensive analysis for global Muscle Relaxers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Muscle Relaxers market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Muscle Relaxers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Muscle Relaxers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Muscle Relaxers market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Muscle Relaxers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Muscle Relaxers market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Viatris, Teva Pharmaceuticals, Endo Pharmaceuticals and Mayne Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Muscle Relaxers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablet
Capsule
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Muscle Relaxers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Muscle Relaxers, with price, sales, revenue and global market share of Muscle Relaxers from 2018 to 2023.
Chapter 3, the Muscle Relaxers competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Muscle Relaxers breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Muscle Relaxers market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Muscle Relaxers.
Chapter 14 and 15, to describe Muscle Relaxers sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Muscle Relaxers
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Muscle Relaxers Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablet
1.3.3 Capsule
1.4 Market Analysis by Application
1.4.1 Overview: Global Muscle Relaxers Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.5 Global Muscle Relaxers Market Size & Forecast
1.5.1 Global Muscle Relaxers Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Muscle Relaxers Sales Quantity (2018-2029)
1.5.3 Global Muscle Relaxers Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Muscle Relaxers Product and Services
2.1.4 Novartis Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Viatris
2.2.1 Viatris Details
2.2.2 Viatris Major Business
2.2.3 Viatris Muscle Relaxers Product and Services
2.2.4 Viatris Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Viatris Recent Developments/Updates
2.3 Teva Pharmaceuticals
2.3.1 Teva Pharmaceuticals Details
2.3.2 Teva Pharmaceuticals Major Business
2.3.3 Teva Pharmaceuticals Muscle Relaxers Product and Services
2.3.4 Teva Pharmaceuticals Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Pharmaceuticals Recent Developments/Updates
2.4 Endo Pharmaceuticals
2.4.1 Endo Pharmaceuticals Details
2.4.2 Endo Pharmaceuticals Major Business
2.4.3 Endo Pharmaceuticals Muscle Relaxers Product and Services
2.4.4 Endo Pharmaceuticals Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Endo Pharmaceuticals Recent Developments/Updates
2.5 Mayne Pharma
2.5.1 Mayne Pharma Details
2.5.2 Mayne Pharma Major Business
2.5.3 Mayne Pharma Muscle Relaxers Product and Services
2.5.4 Mayne Pharma Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mayne Pharma Recent Developments/Updates
2.6 Merck & Co. Inc
2.6.1 Merck & Co. Inc Details
2.6.2 Merck & Co. Inc Major Business
2.6.3 Merck & Co. Inc Muscle Relaxers Product and Services
2.6.4 Merck & Co. Inc Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck & Co. Inc Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Muscle Relaxers Product and Services
2.7.4 GSK Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GSK Recent Developments/Updates
2.8 Casper Pharma LLC
2.8.1 Casper Pharma LLC Details
2.8.2 Casper Pharma LLC Major Business
2.8.3 Casper Pharma LLC Muscle Relaxers Product and Services
2.8.4 Casper Pharma LLC Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Casper Pharma LLC Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Muscle Relaxers Product and Services
2.9.4 Bayer Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bayer Recent Developments/Updates
2.10 BASF
2.10.1 BASF Details
2.10.2 BASF Major Business
2.10.3 BASF Muscle Relaxers Product and Services
2.10.4 BASF Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 BASF Recent Developments/Updates
2.11 ADVIL
2.11.1 ADVIL Details
2.11.2 ADVIL Major Business
2.11.3 ADVIL Muscle Relaxers Product and Services
2.11.4 ADVIL Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ADVIL Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Muscle Relaxers Product and Services
2.12.4 Pfizer Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Johnson & Johnson
2.13.1 Johnson & Johnson Details
2.13.2 Johnson & Johnson Major Business
2.13.3 Johnson & Johnson Muscle Relaxers Product and Services
2.13.4 Johnson & Johnson Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Johnson & Johnson Recent Developments/Updates
2.14 Rosemont Pharmaceuticals
2.14.1 Rosemont Pharmaceuticals Details
2.14.2 Rosemont Pharmaceuticals Major Business
2.14.3 Rosemont Pharmaceuticals Muscle Relaxers Product and Services
2.14.4 Rosemont Pharmaceuticals Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Rosemont Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Muscle Relaxers by Manufacturer
3.1 Global Muscle Relaxers Sales Quantity by Manufacturer (2018-2023)
3.2 Global Muscle Relaxers Revenue by Manufacturer (2018-2023)
3.3 Global Muscle Relaxers Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Muscle Relaxers by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Muscle Relaxers Manufacturer Market Share in 2022
3.4.2 Top 6 Muscle Relaxers Manufacturer Market Share in 2022
3.5 Muscle Relaxers Market: Overall Company Footprint Analysis
3.5.1 Muscle Relaxers Market: Region Footprint
3.5.2 Muscle Relaxers Market: Company Product Type Footprint
3.5.3 Muscle Relaxers Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Muscle Relaxers Market Size by Region
4.1.1 Global Muscle Relaxers Sales Quantity by Region (2018-2029)
4.1.2 Global Muscle Relaxers Consumption Value by Region (2018-2029)
4.1.3 Global Muscle Relaxers Average Price by Region (2018-2029)
4.2 North America Muscle Relaxers Consumption Value (2018-2029)
4.3 Europe Muscle Relaxers Consumption Value (2018-2029)
4.4 Asia-Pacific Muscle Relaxers Consumption Value (2018-2029)
4.5 South America Muscle Relaxers Consumption Value (2018-2029)
4.6 Middle East and Africa Muscle Relaxers Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Muscle Relaxers Sales Quantity by Type (2018-2029)
5.2 Global Muscle Relaxers Consumption Value by Type (2018-2029)
5.3 Global Muscle Relaxers Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Muscle Relaxers Sales Quantity by Application (2018-2029)
6.2 Global Muscle Relaxers Consumption Value by Application (2018-2029)
6.3 Global Muscle Relaxers Average Price by Application (2018-2029)
7 North America
7.1 North America Muscle Relaxers Sales Quantity by Type (2018-2029)
7.2 North America Muscle Relaxers Sales Quantity by Application (2018-2029)
7.3 North America Muscle Relaxers Market Size by Country
7.3.1 North America Muscle Relaxers Sales Quantity by Country (2018-2029)
7.3.2 North America Muscle Relaxers Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Muscle Relaxers Sales Quantity by Type (2018-2029)
8.2 Europe Muscle Relaxers Sales Quantity by Application (2018-2029)
8.3 Europe Muscle Relaxers Market Size by Country
8.3.1 Europe Muscle Relaxers Sales Quantity by Country (2018-2029)
8.3.2 Europe Muscle Relaxers Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Muscle Relaxers Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Muscle Relaxers Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Muscle Relaxers Market Size by Region
9.3.1 Asia-Pacific Muscle Relaxers Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Muscle Relaxers Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Muscle Relaxers Sales Quantity by Type (2018-2029)
10.2 South America Muscle Relaxers Sales Quantity by Application (2018-2029)
10.3 South America Muscle Relaxers Market Size by Country
10.3.1 South America Muscle Relaxers Sales Quantity by Country (2018-2029)
10.3.2 South America Muscle Relaxers Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Muscle Relaxers Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Muscle Relaxers Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Muscle Relaxers Market Size by Country
11.3.1 Middle East & Africa Muscle Relaxers Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Muscle Relaxers Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Muscle Relaxers Market Drivers
12.2 Muscle Relaxers Market Restraints
12.3 Muscle Relaxers Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Muscle Relaxers and Key Manufacturers
13.2 Manufacturing Costs Percentage of Muscle Relaxers
13.3 Muscle Relaxers Production Process
13.4 Muscle Relaxers Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Muscle Relaxers Typical Distributors
14.3 Muscle Relaxers Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
